Nothing Special   »   [go: up one dir, main page]

  EconPapers    
Economics at your fingertips  
 

Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration

Glenn Ellison () and Sara Fisher Ellison

No 13069, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: This paper develops a new approach to testing for strategic entry deterrence and applies it to the behavior of pharmaceutical incumbents just before they lose patent protection. The approach involves looking at a cross-section of markets and examining whether behavior is nonmonotonic in the size of the market. Under certain conditions, investment levels will be monotone in market size if firms are not influenced by a desire to deter entry. Strategic investments, however, may be nonmonotone because entry deterrence is unnecessary in very small markets and impossible in very large ones, resulting in overall nonmonotonic investment. The pharmaceutical data contain advertising, product proliferation, and pricing information for a sample of drugs which lost patent protection between 1986 and 1992. Among the findings consistent with an entry deterrence motivation are that incumbents in markets of intermediate size have lower levels of advertising and are more likely to reduce advertising immediately prior to patent expiration.

JEL-codes: L13 L65 (search for similar items in EconPapers)
Date: 2007-04
New Economics Papers: this item is included in nep-com, nep-ind, nep-ipr, nep-pr~, nep-mic and nep-tid
Note: IO
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (22)

Published as Ellison, Glenn and Sara Fisher Ellison. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration." American Economic Journal: Microeconomics 3, 1 (February 2011): 1-36.

Downloads: (external link)
http://www.nber.org/papers/w13069.pdf (application/pdf)

Related works:
Journal Article: Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:13069

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w13069

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().

 
Page updated 2024-12-10
Handle: RePEc:nbr:nberwo:13069